Ha seleccionado la visión en Inglés
Descriptor en español: |
Proteínas Proto-Oncogénicas c-myc
| ||||||
Descriptor en inglés: | Proto-Oncogene Proteins c-myc | ||||||
Descriptor en portugués: | Proteínas Proto-Oncogênicas c-myc | ||||||
Descriptor en francés: | Protéines proto-oncogènes c-myc | ||||||
Término(s) alternativo(s): |
L myc Proteins L-myc Proteins N myc Proteins N-myc Proteins Proteins myc, Proto-Oncogene Proto Oncogene Products c myc Proto Oncogene Proteins c myc Proto Oncogene Proteins myc Proto-Oncogene Products c-myc Proto-Oncogene Proteins myc Proto-Oncogene Proteins, myc c myc Proteins c-myc Proteins myc Proto Oncogene Product p62 myc Proto Oncogene Proteins myc Proto-Oncogene Product p62 myc Proto-Oncogene Proteins myc, Proto-Oncogene Proteins p62 c myc p62 c-myc p62(c-myc) |
||||||
Código(s) jeráquico(s): |
D12.776.260.103.813 D12.776.624.664.700.189 D12.776.660.765 D12.776.930.125.813 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D016271 | ||||||
Nota de alcance: | Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. |
||||||
Calificadores permitidos: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Indexación anterior: |
Neoplasm Proteins (1983-1984) Phosphoproteins (1985) Proto-Oncogene Proteins (1986-1990) |
||||||
Nota Pública de MeSH: | 91 |
||||||
Nota de historia: | 91 |
||||||
Identificador de DeCS: | 29093 | ||||||
ID del Descriptor: | D016271 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1991 | ||||||
Fecha de entrada: | 19/06/1990 | ||||||
Fecha de revisión: | 01/07/2018 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Proto-Oncogene Proteins c-myc
- Concepto preferido
N-myc Proteins
- Relacionado pero no más amplio ni más estrecho
L-myc Proteins
- Relacionado pero no más amplio ni más estrecho
UI del concepto |
M0024867 |
Nota de alcance | Basic helix-loop-helix transcription factors encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. |
Término preferido | Proto-Oncogene Proteins c-myc |
Término(s) alternativo(s) |
Proteins myc, Proto-Oncogene Proto Oncogene Products c myc Proto Oncogene Proteins c myc Proto Oncogene Proteins myc Proto-Oncogene Products c-myc Proto-Oncogene Proteins myc Proto-Oncogene Proteins, myc c myc Proteins c-myc Proteins myc Proto Oncogene Product p62 myc Proto Oncogene Proteins myc Proto-Oncogene Product p62 myc Proto-Oncogene Proteins myc, Proto-Oncogene Proteins p62 c myc p62 c-myc p62(c-myc) |
UI del concepto |
M0024866 |
Término preferido | N-myc Proteins |
Término(s) alternativo(s) |
N myc Proteins |
UI del concepto |
M0024865 |
Término preferido | L-myc Proteins |
Término(s) alternativo(s) |
L myc Proteins |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta